In contrast, hormone receptor status determined by preoperative biopsy, i.e., loss of progesterone receptor (PR) and double loss of estrogen receptor and PR, were associated with lymph node metastasis [167,168]. The gene discussed is PGR; the disease is metastatic malignant neoplasm in the lymph nodes.